Page 350 - Vitamin D and Cancer
P. 350

st
            15  Assessment of Vitamin D Status in the 21  Century           337
              26. Dawson-Hughes B (2006) Calcium plus vitamin D and the risk of fractures. N Engl J Med
               354:2285–2287
              27. Hollis BW, Wagner CL (2005) Normal serum vitamin D levels. N Engl J Med 352:515–516
              28. Abbas S, Linseisen J, Slanger T et al (2008) Serum 25-hydroxyvitamin D and risk of post-
               menopausal breast cancer – results of a large case-control study. Carcinogenesis 29:93–99
              29. Betone-Johnson ER, Chen WY, Holick MF et al (2005) Plasma 25-hydroxyvitamin D and
               1,25-dihydroxyvitamin  D  and  risk  of  breast  cancer.  Cancer  Epidemiol  Biomarkers  Prev
               14:1991–1997
              30. Feskanich D, Ma J, Fuchs CS et al (2004) Plasma vitamin D metabolites and risk of colorectal
               cancer in women. Cancer Epidemiol Biomarkers Prev 13:1502–1508
              31. Giovannucci E, Liu Y, Rimm EB et al (2006) Prospective study of predictors of vitamin D
               status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451–459
              32.  Zhou W, Heist RS, Liu G et al (2007) Circulating 25-Hydroxyvitamin D levels predict survival
               in early-state non-small-cell lung cancer patients. J Clin Oncol 25:474–485
              33. Tworoger SS, Lee IM, Buring JE et al (2007) Plasma 25-hydroxyvitamin D and 1, 25-dihy-
               droxyvitamin  D  and  risk  of  incident  ovarian  cancer.  Cancer  Epidemiol  Biomarkers  Prev
               16:783–788
             34.  Mikhak B, Hunter DJ, Speigelman D et al (2007) Vitamin D receptor (VDR) gene polymorphisms
               and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D, and
               prostate cancer risk. Prostate 67:911–923
              35.  Wu K, Feskanich D, Fuchs CS et al (2007) A nested case control study of plasma 25-hydroxyvi-
               tamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 99:1120–1129
              36. Wactawski-Wende J, Kotchen JM, Anderson GL et al (2006) Calcium plus vitamin D supple-
               mentation and the risk of colorectal cancer. N Engl J Med 354:684–696
              37. Liu PT, Sterdger S, Li H et al (2006) Toll-like receptor triggering of a vitamin D-mediated
               human antimicrobial response. Science 311:1770–1773
              38. Zasloff M (2006) Fighting infections with vitamin D. Nat Med 12:388–390
             39.  Dietrich  T,  Nunn  M,  Dawson-Hughes  B,  Bischoff-Ferrari  HA  (2005)  Association  between
               serum  concentrations  of  25-hydroxyvitamin  D  and  gingival  inflammation.  Am  J  Clin  Nutr
               82:575–580
              40. Dietrich  T,  Joshipura  KJ,  Dawson-Hughes  B,  Bischoff-Ferrari  HA  (2004)  Association
               between serum concentrations of 25-hydroxyvitamin D and periodontal disease in the US
               population. Am J Clin Nutr 80:108–113
              41. Forman JP, Giovannucci E, Holmes MD et al (2007) Plasma 25-hydroxyvitamin D levels and
               risk of incident hypertension. Hypertension 49:1063–1069
              42. Martins D, Wolf M, Pan D et al (2007) Prevalence of cardiovascular risk factors and the serum
               levels of 25-hydroxyvitamin D in the United States. Arch Intern Med 167:1159–1165
              43. Wang TJ, Pencina MJ, Booth SL et al (2008) Vitamin D deficiency and risk of cardiovascular
               disease. Circulation 117:503–511
              44. Giovannucci  E,  Liu  Y,  Hollis  BW,  Rimm  EB  (2008)  A  prospective  study  of  25-hydroxy-
               vitamin D and risk of myocardial infarction in men. Arch Intern Med 168(11):1174–1180
              45. Chiu KC, Chu A, Go V, Saad MF (2004) Hypovitaminosis D is associated with insulin resis-
               tance and beta cell dysfunction. Amer J Clin Nutr 79:820–825
              46. Zipitis CS, Abodeng AK (2008) Vitamin D supplementation in early childhood and risk of
               type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 93:512–517
              47. Chonchol M, Scragg R (2007) 25-hydroxyvitamin D, insulin resistance and kidney function
               in the third national health and nutrition examination survey. Kidney Int 71:134–139
              48. Munger KL, Levin LI, Hollis BW et al (2006) Serum 25-hydroxyvitamin D levels and risk of
               multiple sclerosis. JAMA 20:2832–2838
              49. Jackson RD, LaCroix AZ, Gass M et al (2006) Calcium plus vitamin D supplementation and
               the risk of fractures. N Engl J Med 354:669–683
              50. Nesby-O’Dell S, Scanlon KS, Cogswell ME et al (2002) Hypovitaminosis D prevalence and
               determinants among African American and white women of reproductive age: third national
               health and nutrition examination survey, 1988–1994. Am J Clin Nutr 76:187–192
   345   346   347   348   349   350   351   352   353   354   355